Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 4
Biomarker-Guided Antidepressant Selection for Treatment-Resistant Depression
Depression is one of the leading causes of disability worldwide. Common treatments like antidepressant medications and talk therapy work well for some people, …
Depression - Major Depressive DisorderTreatment-resistant Depression (TRD)rTMS+2 more
Estimated
~$10 – $6,250
Weill Medical College of Cornell UniversityNCT07680140
Phase 2
A Randomized, Double-blind, Placebo-controlled Trial of ALTO-207 in Adults With Treatment-resistant Depression
The purpose of this trial is to measure depressive symptoms following treatment with ALTO-207 compared with placebo in participants with TRD.
Treatment-resistant Depression (TRD)
Estimated
~$10 – $7,500
Alto NeuroscienceNCT07553637
Observational
Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression (COMBAT-SI)
This is a prospective clinical trial to confirm the effectiveness of bilateral accelerated theta burst stimulation (aTBS) on suicidal ideation (SI), while expl…
Suicidal IdeationTreatment-resistant Depression
Estimated
~$10 – $6,250
University of California, San DiegoNCT05377177
Observational
Parsing Mechanistic Relationships Between Circuits and Negative Valence System Behaviors in Treatment-Resistant Depression With Ultrasound Neuromodulation
Approximately one third of individuals with Major Depressive Disorder (MDD) are considered treatment-resistant, subject to severe disability and risk of suicid…
Treatment-Resistant Depression
Estimated
~$10 – $8,750
Laureate Institute for Brain Research, Inc.NCT07166289